Inhibrx Biosciences Files Q1 2025 10-Q
Ticker: INBX · Form: 10-Q · Filed: May 14, 2025 · CIK: 2007919
| Field | Detail |
|---|---|
| Company | Inhibrx Biosciences, Inc. (INBX) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotechnology, financial-reporting
TL;DR
Inhibrx Biosciences filed its Q1 2025 10-Q, showing financial updates for the period ending March 31.
AI Summary
Inhibrx Biosciences, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Ibex SpinCo, Inc. until January 11, 2024, is based in La Jolla, CA. The filing details financial information and business operations for the first quarter of 2025.
Why It Matters
This filing provides investors with an update on Inhibrx Biosciences' financial health and operational status for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a biotechnology company, Inhibrx Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-14 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
- 2024-01-11 — Name Change Date (Date when the company changed its name from Ibex SpinCo, Inc. to Inhibrx Biosciences, Inc.)
Key Players & Entities
- Inhibrx Biosciences, Inc. (company) — Filer of the 10-Q report
- Ibex SpinCo, Inc. (company) — Former name of Inhibrx Biosciences, Inc.
- 20250331 (date) — End of the reporting period
- 20250514 (date) — Filing date of the report
- La Jolla, CA (location) — Business and mailing address of the company
FAQ
What is the primary business of Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. is in the business of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
When did Inhibrx Biosciences, Inc. change its name?
The company changed its name from Ibex SpinCo, Inc. on January 11, 2024.
What is the fiscal year end for Inhibrx Biosciences, Inc.?
The company's fiscal year ends on December 31.
Where is Inhibrx Biosciences, Inc. located?
The company's business and mailing address is 11025 N. Torrey Pines Road, Suite 140, La Jolla, CA 92037.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Inhibrx Biosciences, Inc. (INBX).